Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease

Diagnosis and care coordination of patients suffering from pulmonary embolism (PE) can be challenging, with the average arrival-to-treatment times lasting more than 8 hours. Viz.ai uses deep learning to identify suspected pulmonary embolism disease in under two minutes. SAN FRANCISCO & ORLANDO, Fla.--(BUSINESS WIRE)--Viz.ai - the world leader in AI-driven intelligent care coordination, today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Viz.ai is the only software company to offer an AI-powered care coordination solution for stroke, aortic disease, and pulmonary embolism. About Pulmonary Embolism and Aortic DiseasePulmonary embolism (PE) is a potentially deadly form of venous thromboembolic disease affecting over 600,000 people worldwide.